Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience

BACKGROUND: Sofosbuvir (SOF)-based regimens achieve excellent efficacy and safety in the treatment of chronic hepatitis C (CHC) with various genotypes. There are few real-world instances of the use of SOF-based regimens to treat genotype 2 CHC. This study determines the effectiveness and safety of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wei-Lun, Wang, Chih-Feng, Cheng, Jin-Shiung, Chen, Wen-Chi, Bair, Ming-Jong, Lo, Ching-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953822/
https://www.ncbi.nlm.nih.gov/pubmed/31923251
http://dx.doi.org/10.1371/journal.pone.0227424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953822/
https://www.ncbi.nlm.nih.gov/pubmed/31923251
http://dx.doi.org/10.1371/journal.pone.0227424

Ejemplares similares